References
- Alavian SM, Fallahian F, Lankarani KB (2007). The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis, 16, 403-6.
- Anand R (2002). Aflatoxins, in: IARC monograph on the evaluation of carcinogenic risks to humans, vol. 82, in: Some Traditional Herbal Medicines Some Mycotoxins, Naphthalene and Styrene, McGraw-Hill, New York, 171-300.
- Bae JM, Jung KW, Won YJ (2002). Estimation of cancer deaths in Korea for the upcoming years. J Korean Med Sci, 17, 611-5. https://doi.org/10.3346/jkms.2002.17.5.611
- Blumberg BS (2010). Primary and secondary prevention of liver cancer caused by HBV. Front Biosci (Schol Ed), 1, 756-63.
- Cai L, Chongsuvivatwong V, Geater A (2008). Changing pattern of premature mortality burden over 6 years of rapid growth of the economy in suburban south-west China: 1998-2003. Public Health, 122, 478-86. https://doi.org/10.1016/j.puhe.2007.08.017
- CDC (2003). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR, 52, 868-9.
- Chang MH, Chen CJ, Lai MS, et al (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med, 336, 1855-9. https://doi.org/10.1056/NEJM199706263362602
- Chen JG, Zhang SW (2011). Liver cancer epidemic in China: past, present and future. Semin Cancer Biol, 21, 59-69. https://doi.org/10.1016/j.semcancer.2010.11.002
- Colombo M, Kuo G, Choo Q, et al (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with Hepatocellular carcinoma. Lancet, 2, 1006-8.
- Chen DS (1993). From hepatitis to hepatoma: lessons from type B viral hepatitis. Science, 262, 369-70. https://doi.org/10.1126/science.8211155
- Chen DS (1995). Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Princess Takamatsu Symp, 25, 27-32.
- Chen CH, Chen YY, Chen GH, et al (2004). Hepatitis B virus and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma. J Hepatol, 40, 653-9 https://doi.org/10.1016/j.jhep.2003.12.002
- Chen CJ, Yu MW, Liaw YF (1997). Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol, 12, 294-308. https://doi.org/10.1111/j.1440-1746.1997.tb00513.x
- Chuang SC, La Vecchia C, Boffetta P (2009). Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett, 286, 9-14. https://doi.org/10.1016/j.canlet.2008.10.040
- Deuffic S, Poynard T, Buffa L, Valleron AJ (1998). Trends in primary liver cancer. Lancet, 351, 214-5.
- Di Bisceglie AM, Lyra AC, Schwartz M, et al (2003). Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol, 98, 2060-3.
- Drinking in the United States: main findings from the 1992 National Longitudinal Alcohol Epidemiology Survey (NLAES) (1998). US Alcohol epidemiology Data Reference Manual, Volume 6, First Edition. NIAAA/NIH NIH Publication No. 99-3519.
- Fallot G, Neuveut C, Buendia MA (2012). Diverse roles of hepatitis B virus in liver cancer. Curr Opin Virol, 2, 467-73. https://doi.org/10.1016/j.coviro.2012.05.008
- Gomaa AI, Khan SA, Toledano MB, et al (2008). Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol, 14, 4300-8. https://doi.org/10.3748/wjg.14.4300
- Gwack J, Park SK, Lee EH, et al (2011). Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents. Asian Pac J Cancer Prev, 12, 2205-8.
- Hajiani E, Masjedzadeh R, Hasehemi J, et al (2005). Risk factors for hepatocellulr carcinoma in southern Iran. Saudi Med J, 26, 974-7.
- Han KH, Ahn SH (2005). How to predict HCC development in patents with chronic B-viral liver disease? Intervirology, 48, 23-8. https://doi.org/10.1159/000082091
- Huang JQ, Zheng GF, Lai CL, et al (2011). Risk of liver cancer in patients with hepatitis B or C. Hong Kong Med J, 17, 41-3.
- IARC (1987). Monographs, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vol. 1-42, supplement 7. Lyon: IARC Press.
- Kao JH, Chen DS (2005). Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int, 25, 696-703. https://doi.org/10.1111/j.1478-3231.2005.01139.x
- Kao JH, Tsai SL, Chen PJ, et al (1994). A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol, 21, 244-9. https://doi.org/10.1016/S0168-8278(05)80403-9
- Kao JH, Chen DS (1999). Hepatocellular carcinoma in Taiwan: progress in the past decade 1988-1997. In: Leong ASY, Liew CT, Lau JWY, Johnson PJ, eds. Hepatocellular Carcinoma: Contemporary Diagnosis, Investigation and Management. London: Arnold, 235-50.
- Kim SR, Kudo M, Hino O, et al (2008). Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology, 75, 13-6. https://doi.org/10.1159/000173419
- Kumar V, Fausto N, Abbas A (editors) (2003). Robbins & Cotran Pathologic Basis of Disease (7th ed.). Saunders. pp. 914-7.
- Koriech O, Al-Kuhaymi R (1994). Profile of cancer in Riyadh armed forces hospital. Ann Saudi Med, 14, 187-94.
- Lai EC, Lau WY (2005). The continuing challenge of hepatic cancer in Asia. Surgeon, 3, 210-5. https://doi.org/10.1016/S1479-666X(05)80043-5
- Law MG, Roberts SK, Dore GJ, Kaldor JM (2000). Primary hepatocellular carcinoma in Australia, 1978-1997: Increasing incidence and mortality. Med J Aust, 173, 403-5.
- Liu Y, Chang CC, Marsh GM, Wu F (2012). Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer, 48, 2125-36. https://doi.org/10.1016/j.ejca.2012.02.009
- Liu Y, Wu F (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect, 118, 818-24. https://doi.org/10.1289/ehp.0901388
- Makimoto K, Higuchi S (1999). Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol, 28, 30-4. https://doi.org/10.1093/ije/28.1.30
- Matsuda T, Saika K (2012). Trends in liver cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database. Jpn J Clin Oncol, 42, 360-1. https://doi.org/10.1093/jjco/hys048
- McGlynn KA, London WT (2005). Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol, 19, 3-23. https://doi.org/10.1016/j.bpg.2004.10.004
- McGlynn KA, Tsao L, Hsing AW, et al (2001). International trends and patterns of primary liver cancer. Int J Cancer, 94, 290-6. https://doi.org/10.1002/ijc.1456
- Merat S, Malekzadeh R, Rezvan H, Khatibian M (2000). Hepatitis B in Iran. Arch Iran Med, 3, 192-201.
- Ming L, Thorgeirsson SS, Gail MH, et al (2002). Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology, 36, 1214-20. https://doi.org/10.1053/jhep.2002.36366
- Noh DK, Choi KS, Jun JK, et al (2012). Factors associated with attending the national cancer screening program for liver cancer in Korea. Asian Pac J Cancer Prev, 13, 731-6. https://doi.org/10.7314/APJCP.2012.13.2.731
- Okuda K (1992). Hepatocellular carcinoma: Recent progress. Hepatology, 5, 948-63.
- Oshima A, Tsukuma H, Hiyama T, et al (1984). Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer, 34, 775-9. https://doi.org/10.1002/ijc.2910340607
- Park JW, Kim CM (2005). Epidemiology of heptocellular carcinoma in Korea. Korean J Hepatol, 11, 303-10.
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer Incidence in Five Continents IARC Scientific Publications No. 155, vol. VIII. Lyon: IARC Press.
- Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM (2010). Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev, 11, 859-62.
- Qian GS, Ross RK, Yu MC, et al (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, people's republic of China. Cancer Epidemiol Biomarkers Prev, 3, 3-10.
- Siddique I, El-Naga HA, Memon A, et al (2004).CLIP score as a prognostic indicator for Hepatocellular carcinoma: experience with patients in the Middle East. Euro J Gastro Hepatol, 16, 675-80. https://doi.org/10.1097/01.meg.0000108338.41221.ec
- Sin HR, Lee CU, Park HJ, et al (1996). Hepatitis B and C virus, for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol, 25, 933-40. https://doi.org/10.1093/ije/25.5.933
- Shamszad M, Farzadgan H (1982). Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran. J Iranian Med Council, 8, 238.
- Sun CA,Wu DM, Lin CC, et al (2003). Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol, 157, 674-82. https://doi.org/10.1093/aje/kwg041
- Taylor-Robinson SD, Foster GR, Arora S, et al (1997). Increase in primary liver cancer in the UK, 1979-1994. Lancet, 350, 1142-3.
- Teo EK, Fock KM (2001). Hepatocellular Carcinoma: An Asian Perspective. Dig Dis, 19, 263-8. https://doi.org/10.1159/000050692
- Yang GH, Wang JF, Wan X, et al (2005). Quantitative analysis of factors affected mortality trend in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi, 26, 934-8.
- Yoshimi I, Sobue T (2003). Mortality trend of liver cancer in Japan: 1960-2000. Jpn J Clin Oncol, 33, 202-3.
- You SL ,Yang HI, Chen CJ (2004). Seropositivity of hepatitis B e antigen and hepatocellular carcinoma. Ann Med, 36, 215-24. https://doi.org/10.1080/07853890310021580
- Yu MC, Yuan, J-M, Govindarajan S, Ross RK (2000). Epidemiology of hepatocellular carcinoma. Can J Gastroenterol, 14, 703-9.
- World Health Organization (2007). Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/.
Cited by
- Cytotoxicity Assessments of Portulaca oleracea and Petroselinum sativum Seed Extracts on Human Hepatocellular Carcinoma Cells (HepG2) vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6633
- Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma Cells vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2655
- DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10917
- Portulaca oleracea Seed Oil Exerts Cytotoxic Effects on Human Liver Cancer (HepG2) and Human Lung Cancer (A-549) Cell Lines vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3383
- Epidemiology of hepatitis C virus in Iran vol.21, pp.38, 2015, https://doi.org/10.3748/wjg.v21.i38.10790
- Hepatocellular carcinoma in Asia: Prevention strategy and planning vol.7, pp.12, 2015, https://doi.org/10.4254/wjh.v7.i12.1708